Longevity Acquisition Overview
Latest ROE for Longevity Acquisition: -1.05% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-1.05%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for LOAC is -1.05%. That is above the sector sector average of -4.47%. Investors often review this figure alongside Longevity Acquisition's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, LOAC currently prints -1.05% for ROE, while the sector average sits near -4.47%. That is roughly 76.6% above the sector mean. Large gaps often invite a closer look at Longevity Acquisition's growth, margins, and balance sheet.
Return on Equity shows how effectively Longevity Acquisition converts resources into returns. At -1.05%, LOAC may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting LOAC's ROE (-1.05%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
